---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-001941"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2022-01-21T23:59:59+00:00"
generated_at: "2026-06-27T16:29:39.075239+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lipocine CFO Morgan Brown resigns effective Jan 31; Krista Fogarty appointed Principal Accounting Officer

## Summary
- Morgan Brown resigns as EVP and CFO, effective Jan 31, 2022; no disagreement with company.
- CEO Mahesh Patel will serve as interim Principal Financial Officer until successor is appointed.
- Krista Fogarty, Corporate Controller, appointed Principal Accounting Officer effective Jan 19, 2022.
- Fogarty has prior CFO and controller experience at biotech and pharma companies including NPS Pharmaceuticals.

## SEC filing metadata
- accession: 0001493152-22-001941
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2022-01-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-001941
- JSON: https://secwatch.observer/filing/0001493152-22-001941.json
- Plain text: https://secwatch.observer/filing/0001493152-22-001941.txt

## Key facts
- Executive change
  Morgan Brown resigned as Executive Vice President and Chief Financial Officer at Lipocine Inc..
  - Action: resigned
  - Role: Executive Vice President and Chief Financial Officer
  source text: On January 17, 2022, Morgan Brown provided Lipocine, Inc. (the “Company”) with notice of his intent to resign from his position as Executive Vice President and Chief Financial Officer of the Company, effective as of January 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm
- Executive change
  Mahesh Patel changed role as Principal Financial Officer at Lipocine Inc..
  - Action: will serve as
  - Role: Principal Financial Officer
  source text: Upon the effective date of Mr. Brown’s resignation, Mahesh Patel, the Company’s President and Chief Executive Officer, will serve as the Company’s Principal Financial Officer on an interim basis until Mr. Brown’s successor is appointed.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm
- Executive change
  Krista Fogarty was appointed as Principal Accounting Officer at Lipocine Inc..
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: On January 19, 2022, the Board of Directors of the Company appointed Krista Fogarty, the Company’s Corporate Controller, to also serve as the Principal Accounting Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315222001941/0001493152-22-001941-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.